PlexBio
Biotechnology Research • 
Neihu District, Taipei City, Taiwan, Province of China • 21-50 Employees
Company overview
| Headquarters | 6F-1, No. 351, Yangguang Street, Neihu District,, Taipei, 11491, TW |
| Phone number | +886226275878 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Functional Recombinant Protein, Immunoassay/Molecular Assay Kits, Multiplexing Using Π Code Microdisc |
| Founded | 2010 |
| Employees | 21-50 |
| Socials |
Key Contacts at PlexBio
Plexbio Co
International Sales Marketing Director
Vipe Cheng
Director
Lloyd Kao
Instrumentation Assitant Director
PlexBio Email Formats
PlexBio uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@plexbio.com), used 62.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@plexbio.com | 62.5% |
{first initial}.{last name} | j.doe@plexbio.com | 18.8% |
{first initial} | j@plexbio.com | 12.5% |
{first initial}{last name} | jdoe@plexbio.com | 6.2% |
About PlexBio
PlexBio Co., Ltd., established in May 2010 to designs, develops and manufactures of IVD products and instrumentations in ISO-certified facilities. To this date, PlexBio has expanded from its headquarters in Taipei, Taiwan to Jiangsu Province, China and has an Innovative Technology Center in San Francisco, USA. Currently, PlexBio is a listed company at Taiwan emerging stock market. In order to address the issue of rising healthcare costs and an increasing range of available tests, it is crucial for clinical and research labs to consider the cost of labor, sample volume, time and maintenance when it comes to assay formats. Therefore, PlexBio aims to provide a cutting-edge multiplexing platform using patented Precision Image Code (π Code) MicroDisc technology to overcome this limitation. Our π Code Microdisc technology is currently the largest multiplexing platform, capable of generating around 16,000 circular image patterns. Each image pattern corresponds to an individual target and can be detected simultaneously via advanced optical imaging and fluorescence analyzers. By using our multiplexing platform, we are able to offer highly sensitive and specific results with low sample volumes, which save time and labor. Currently, PlexBio is researching and developing high-quality reagents focusing on companion diagnostics, early cancer detection, prenatal diagnostics and food safety testing with ultra-detection sensitivity and fully automated diagnostics instruments for high-throughput clinical needs. With our innovative technologies, PlexBio intends to revolutionize the IVD industry developments, placing PlexBio as the leading brand of global IVD market.
PlexBio revenue & valuation
| Annual revenue | $2,823,315 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
PlexBio has 14 employees across 6 departments.
Departments
Number of employees
Funding Data
PlexBio has never raised funding before.
PlexBio Tech Stack
Discover the technologies and tools that power PlexBio's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Tag managers
Hosting
Reverse proxies
JavaScript libraries
Programming languages
JavaScript libraries
Miscellaneous
JavaScript frameworks
Authentication
JavaScript libraries
United States
Sweden
Canada
ItalyFrequently asked questions
4.8
40,000 users
